等待开盘 03-26 09:30:00 美东时间
+0.450
+0.95%
今日重点评级关注:Guggenheim:维持Cabaletta Bio"买入"评级,目标价从15美元升至16美元;HC Wainwright & Co.:维持Palvella Therapeutics"买入"评级,目标价从255美元升至270美元
03-25 10:31
BMO Capital analyst Brennan Hawken maintains StepStone Group (NASDAQ:STEP) with a Outperform and lowers the price target from $70 to $58.
03-25 01:49
StepStone Group Inc. (NASDAQ:STEP) today announced that its Board of Directors authorized a stock repurchase program of up to $100 million of the company's Class A common stock."Our capital‑efficient business model
03-10 04:12
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
Shares of companies within the broader financial sector are trading lower amid ...
02-28 04:17
今日重点评级关注:瑞杰金融:上调Lumexa Imaging Holdings评级至"强力买入",目标价23美元;BTIG:维持Transocean"买入"评级,目标价从6美元升至10美元
02-10 10:29
今日重点评级关注:HC Wainwright & Co.:维持NovaBridge Biosciences"买入"评级,目标价从7美元升至9美元;Truist Securities:维持Reddit"买入"评级,目标价从270美元升至275美元
02-09 14:37
JP Morgan analyst Kenneth Worthington maintains StepStone Group (NASDAQ:STEP) with a Overweight and raises the price target from $84 to $91.
02-07 04:59
华盛资讯2月6日讯,StepStone Group, Inc. Class A公布2025财年Q4业绩,公司Q4营收5.87亿美元,同比增长73.0%,归母净利润亏损1.23亿美元,同比亏损缩窄35.7%。
02-06 14:48
华盛资讯2月6日讯,StepStone Group, Inc. Class A公布2025财年Q4业绩,公司Q4营收5.87亿美元,同比增长73.0%,归母净利润亏损1.23亿美元,同比亏损缩窄35.7%。
02-06 13:21